ETIG Analysis: Five reasons why the pharma sector has been the biggest beneficiary of the pandemic

The events of the recent months prompted the government to roll out an incentive scheme to promote the local production of key active ingredients in a bid to stave off the Chinese threat to the supplies of raw materials to the export-oriented pharma industry.

from Markets-Economic Times https://ift.tt/3kUfjZ0